Managing early complications in total hip arthroplasty: the safety of immediate revision

Descamps, Jules; Teissier, Victoria; Graff, Wilfrid; Mouton, Antoine; Bouché, Pierre-Alban; Marmor, Simon

doi:10.1186/s10195-023-00719-1

Cited by 9 publications

(2 citation statements)

References 30 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The most significant difference in aseptic loosening rate was noted after CMAI and SAI implantation in pelvic discontinuities with uncontaminated bone defects (0% and 60.0%, respectively; P<.001). 6 (Descamps et al, 2023) Managing early complications in total hip arthroplasty: the safety of immediate revision No infections were observed within two years after index arthroplasty. Limb length discrepancy (88%, n=37) and dislocation (7.1%, n=3) were the leading causes of immediate revision.…”

Section: Resultsmentioning

confidence: 99%

Revision Rates and Causes in Total Hip Replacement: A Systematic Review

Ceelvin Lengkong

2024

JWS

View full text Add to dashboard Cite

Total hip replacement is a common surgery to treat severe hip joint pain and dysfunction. Although total hip replacement is generally safe and effective, complications, including revision, are risks. This study aimed to systematically review the literature to analyze revision rates and causes of total hip replacement. This research uses a systematic literature review method following PRISMA guidelines. The data collection technique in this research uses literature study techniques. Literature searches were conducted in electronic databases such as PubMed, Scopus, and Google Scholar. The data that has been collected is then analyzed in three stages, namely data reduction, data presentation, and conclusion. The results showed that factors such as infection, dislocation, limb length discrepancy, and other complications play an important role in determining the revision rate and success of replacement. Precautions include using a povidone-iodine mouthwash before treatment to reduce the risk of infection and implementing better blood management protocols to optimize total hip replacement results. This study implies an in-depth understanding of the risk factors associated with revision total hip replacement, which is essential in managing patients undergoing this procedure. By paying closer attention to these factors, medical practitioners can increase the success of total hip replacement and reduce the number of revisions required, thereby improving patients' quality of life.

show abstract

Section: Resultsmentioning

confidence: 99%

Revision Rates and Causes in Total Hip Replacement: A Systematic Review

Ceelvin Lengkong

2024

JWS

View full text Add to dashboard Cite

show abstract

“…Hip osteoarthritis is a common cause of pain and disability [ 1 – 4 ]. In patients with advanced osteoarthritis, total hip arthroplasty (THA) is commonly recommended [ 3 , 5 – 7 ]. THA demonstrated very good outcomes, improving patient quality of life and participation in recreational activities [ 8 – 14 ].…”

Section: Introductionmentioning

confidence: 99%

Antithrombotic prophylaxis following total hip arthroplasty: a level I Bayesian network meta-analysis

Migliorini,

Maffulli,

Velaj

et al. 2024

J Orthop Traumatol

View full text Add to dashboard Cite

Background Several clinical investigations have compared different pharmacologic agents for the prophylaxis of venous thromboembolism (VTE). However, no consensus has been reached. The present investigation compared enoxaparin, fondaparinux, aspirin and non-vitamin K antagonist oral anticoagulants (NOACs) commonly used as prophylaxis following total hip arthroplasty (THA). A Bayesian network meta-analysis was performed, setting as outcomes of interest the rate of deep venous thrombosis (DVT), pulmonary embolism (PE) and major and minor haemorrhages. Methods This study was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) extension statement for reporting systematic reviews incorporating network meta-analyses of healthcare interventions. All randomised controlled trials (RCTs) comparing two or more drugs used for the prophylaxis of VTE following THA were accessed. PubMed, Web of Science and Google Scholar databases were accessed in March 2023 with no time constraint. Results Data from 31,705 patients were extracted. Of these, 62% (19,824) were women, with age, sex ratio, and body mass index (BMI) being comparable at baseline. Apixaban 5 mg, fondaparinux, and rivaroxaban 60 mg were the most effective in reducing the rate of DVT. Dabigatran 220 mg, apixaban 5 mg, and aspirin 100 mg were the most effective in reducing the rate of PE. Apixaban 5 mg, ximelagatran 2 mg and aspirin 100 mg were associated with the lowest rate of major haemorrhages, while rivaroxaban 2.5 mg, apixaban 5 mg and enoxaparin 40 mg were associated with the lowest rate of minor haemorrhages. Conclusion Administration of apixaban 5 mg demonstrated the best balance between VTE prevention and haemorrhage control following THA. Level of evidence Level I, network meta-analysis of RCTs.

show abstract